This will likely be cell (patient/cancer genome) specific and influenced by the cellular environment, especially as cell density or cell number can impact on MDM2 levels 19 and heterogeneity in p53 protein levels in cancers in vivo 29. This evidence concerns the gene TP53 and cancer.